Statistics in medicine
-
Statistics in medicine · Jul 2012
Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
In this paper, we compare the robustness properties of a matching estimator with a doubly robust estimator. We describe the robustness properties of matching and subclassification estimators by showing how misspecification of the propensity score model can result in the consistent estimation of an average causal effect. The propensity scores are covariate scores, which are a class of functions that removes bias due to all observed covariates. ⋯ The implication is that there are multiple possibilities for the matching estimator in contrast to the doubly robust estimator in which the researcher has two chances to make reliable inference. In simulations, we compare the finite sample properties of the matching estimator with a simple inverse probability weighting estimator and a doubly robust estimator. For the misspecifications in our study, the mean square error of the matching estimator is smaller than the mean square error of both the simple inverse probability weighting estimator and the doubly robust estimators.
-
Statistics in medicine · May 2012
Competing risks and the clinical community: irrelevance or ignorance?
Life expectancy has dramatically increased in industrialized nations over the last 200 hundred years. The aging of populations carries over to clinical research and leads to an increasing representation of elderly and multimorbid individuals in study populations. Clinical research in these populations is complicated by the fact that individuals are likely to experience several potential disease endpoints that prevent some disease-specific endpoint of interest from occurrence. ⋯ We then discuss the importance of agreement between the competing risks methodology and the study aim, in particular the distinction between etiologic and prognostic research questions. In a review of 50 clinical studies performed in individuals susceptible to competing risks published in high-impact clinical journals, we found competing risks issues in 70% of all articles. Better recognition of issues related to competing risks and of statistical methods that deal with competing risks in accordance with the aim of the study is needed.
-
Statistics in medicine · May 2012
Bayesian adaptive clinical trials: a dream for statisticians only?
Adaptive or 'flexible' designs have emerged, mostly within frequentist frameworks, as an effective way to speed up the therapeutic evaluation process. Because of their flexibility, Bayesian methods have also been proposed for Phase I through Phase III adaptive trials; however, it has been reported that they are poorly used in practice. We aim to describe the international scientific production of Bayesian clinical trials by investigating the actual development and use of Bayesian 'adaptive' methods in the setting of clinical trials. ⋯ The spread and use of these articles depended heavily on their topic, with 3.1% of the biostatistical articles accumulating at least 25 citations within 5 years of their publication compared with 15% of the reviews and 32% of the clinical articles. We also examined the reasons for the limited use of Bayesian adaptive design methods in clinical trials and the areas of current and future research to address these challenges. Efforts to promote Bayesian approaches among statisticians and clinicians appear necessary.
-
Statistics in medicine · Nov 2011
Power and sample size evaluation for the Cochran-Mantel-Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend.
The power of a chi-square test, and thus the required sample size, are a function of the noncentrality parameter that can be obtained as the limiting expectation of the test statistic under an alternative hypothesis specification. Herein, we apply this principle to derive simple expressions for two tests that are commonly applied to discrete ordinal data. The Wilcoxon rank sum test for the equality of distributions in two groups is algebraically equivalent to the Mann-Whitney test. ⋯ These expressions yield results virtually identical to those derived previously for rank scores and also apply to other score functions. The Cochran-Armitage test for trend assesses whether there is an monotonically increasing or decreasing trend in the proportions with a positive outcome or response over the C-ordered categories of an ordinal independent variable, for example, dose. Herein, it is shown that the power of the test is a function of the slope of the response probabilities over the ordinal scores assigned to the groups that yields simple expressions for the power of the test.